Logo image of PATH

UIPATH INC - CLASS A (PATH) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:PATH - US90364P1057 - Common Stock

13.01 USD
+0.28 (+2.2%)
Last: 11/21/2025, 8:04:00 PM
13.08 USD
+0.07 (+0.54%)
Pre-Market: 11/24/2025, 6:37:51 AM
Fundamental Rating

5

Taking everything into account, PATH scores 5 out of 10 in our fundamental rating. PATH was compared to 280 industry peers in the Software industry. No worries on liquidiy or solvency for PATH as it has an excellent financial health rating, but there are worries on the profitability. PATH is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year PATH was profitable.
In the past year PATH had a positive cash flow from operations.
In the past 5 years PATH always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: PATH reported negative operating cash flow in multiple years.
PATH Yearly Net Income VS EBIT VS OCF VS FCFPATH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

1.2 Ratios

The Return On Assets of PATH (0.78%) is better than 60.36% of its industry peers.
PATH has a better Return On Equity (1.21%) than 63.21% of its industry peers.
Industry RankSector Rank
ROA 0.78%
ROE 1.21%
ROIC N/A
ROA(3y)-5.87%
ROA(5y)-9.74%
ROE(3y)-8.52%
ROE(5y)-15%
ROIC(3y)N/A
ROIC(5y)N/A
PATH Yearly ROA, ROE, ROICPATH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200 -250

1.3 Margins

PATH has a better Profit Margin (1.35%) than 61.79% of its industry peers.
Looking at the Gross Margin, with a value of 83.06%, PATH belongs to the top of the industry, outperforming 89.29% of the companies in the same industry.
In the last couple of years the Gross Margin of PATH has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 1.35%
GM 83.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y0.08%
PATH Yearly Profit, Operating, Gross MarginsPATH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

8

2. Health

2.1 Basic Checks

PATH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PATH has less shares outstanding
The number of shares outstanding for PATH has been increased compared to 5 years ago.
There is no outstanding debt for PATH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PATH Yearly Shares OutstandingPATH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
PATH Yearly Total Debt VS Total AssetsPATH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 4.53 indicates that PATH is not in any danger for bankruptcy at the moment.
PATH has a better Altman-Z score (4.53) than 70.36% of its industry peers.
PATH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.53
ROIC/WACCN/A
WACC10.99%
PATH Yearly LT Debt VS Equity VS FCFPATH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.75 indicates that PATH has no problem at all paying its short term obligations.
PATH has a Current ratio of 2.75. This is in the better half of the industry: PATH outperforms 73.93% of its industry peers.
PATH has a Quick Ratio of 2.75. This indicates that PATH is financially healthy and has no problem in meeting its short term obligations.
PATH has a better Quick ratio (2.75) than 74.64% of its industry peers.
Industry RankSector Rank
Current Ratio 2.75
Quick Ratio 2.75
PATH Yearly Current Assets VS Current LiabilitesPATH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

7

3. Growth

3.1 Past

PATH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.53%, which is quite impressive.
Measured over the past years, PATH shows a very strong growth in Earnings Per Share. The EPS has been growing by 88.99% on average per year.
The Revenue has grown by 8.25% in the past year. This is quite good.
The Revenue has been growing by 33.58% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)23.53%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%275%
Revenue 1Y (TTM)8.25%
Revenue growth 3Y17.01%
Revenue growth 5Y33.58%
Sales Q2Q%14.38%

3.2 Future

PATH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.84% yearly.
The Revenue is expected to grow by 11.61% on average over the next years. This is quite good.
EPS Next Y24.86%
EPS Next 2Y18.22%
EPS Next 3Y16.03%
EPS Next 5Y1.84%
Revenue Next Year9.93%
Revenue Next 2Y9.36%
Revenue Next 3Y8.81%
Revenue Next 5Y11.61%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PATH Yearly Revenue VS EstimatesPATH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B 2B 2.5B
PATH Yearly EPS VS EstimatesPATH Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.2 0.4 0.6 0.8

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.65, which indicates a rather expensive current valuation of PATH.
PATH's Price/Earnings ratio is a bit cheaper when compared to the industry. PATH is cheaper than 72.14% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.47, PATH is valued at the same level.
The Price/Forward Earnings ratio is 17.24, which indicates a rather expensive current valuation of PATH.
Based on the Price/Forward Earnings ratio, PATH is valued a bit cheaper than the industry average as 76.79% of the companies are valued more expensively.
PATH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 34.42, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.65
Fwd PE 17.24
PATH Price Earnings VS Forward Price EarningsPATH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

76.07% of the companies in the same industry are more expensive than PATH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 22.31
EV/EBITDA N/A
PATH Per share dataPATH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PATH's earnings are expected to grow with 16.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.83
PEG (5Y)N/A
EPS Next 2Y18.22%
EPS Next 3Y16.03%

0

5. Dividend

5.1 Amount

PATH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UIPATH INC - CLASS A

NYSE:PATH (11/21/2025, 8:04:00 PM)

Premarket: 13.08 +0.07 (+0.54%)

13.01

+0.28 (+2.2%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-04 2025-09-04/amc
Earnings (Next)12-03 2025-12-03/amc
Inst Owners82.05%
Inst Owner Change-22.15%
Ins Owners9.51%
Ins Owner Change4.24%
Market Cap6.91B
Revenue(TTM)1.50B
Net Income(TTM)20.17M
Analysts66.21
Price Target13.8 (6.07%)
Short Float %11.69%
Short Ratio1.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)45.52%
Min EPS beat(2)7.36%
Max EPS beat(2)83.69%
EPS beat(4)4
Avg EPS beat(4)41.39%
Min EPS beat(4)7.36%
Max EPS beat(4)83.69%
EPS beat(8)8
Avg EPS beat(8)37.53%
EPS beat(12)12
Avg EPS beat(12)102.79%
EPS beat(16)16
Avg EPS beat(16)96.54%
Revenue beat(2)2
Avg Revenue beat(2)3.57%
Min Revenue beat(2)2.11%
Max Revenue beat(2)5.03%
Revenue beat(4)3
Avg Revenue beat(4)1.2%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)5.03%
Revenue beat(8)6
Avg Revenue beat(8)1.29%
Revenue beat(12)9
Avg Revenue beat(12)2.25%
Revenue beat(16)13
Avg Revenue beat(16)2.53%
PT rev (1m)3.59%
PT rev (3m)-1.67%
EPS NQ rev (1m)-0.24%
EPS NQ rev (3m)26.43%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)21.66%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.16%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.44%
Valuation
Industry RankSector Rank
PE 20.65
Fwd PE 17.24
P/S 4.62
P/FCF 22.31
P/OCF 20.64
P/B 4.15
P/tB 4.54
EV/EBITDA N/A
EPS(TTM)0.63
EY4.84%
EPS(NY)0.75
Fwd EY5.8%
FCF(TTM)0.58
FCFY4.48%
OCF(TTM)0.63
OCFY4.85%
SpS2.82
BVpS3.14
TBVpS2.87
PEG (NY)0.83
PEG (5Y)N/A
Graham Number6.67
Profitability
Industry RankSector Rank
ROA 0.78%
ROE 1.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.35%
GM 83.06%
FCFM 20.69%
ROA(3y)-5.87%
ROA(5y)-9.74%
ROE(3y)-8.52%
ROE(5y)-15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y0.08%
F-Score7
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 164.78%
Cap/Sales 1.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 1535.31%
Current Ratio 2.75
Quick Ratio 2.75
Altman-Z 4.53
F-Score7
WACC10.99%
ROIC/WACCN/A
Cap/Depr(3y)82.11%
Cap/Depr(5y)72.19%
Cap/Sales(3y)1.29%
Cap/Sales(5y)1.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.53%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%275%
EPS Next Y24.86%
EPS Next 2Y18.22%
EPS Next 3Y16.03%
EPS Next 5Y1.84%
Revenue 1Y (TTM)8.25%
Revenue growth 3Y17.01%
Revenue growth 5Y33.58%
Sales Q2Q%14.38%
Revenue Next Year9.93%
Revenue Next 2Y9.36%
Revenue Next 3Y8.81%
Revenue Next 5Y11.61%
EBIT growth 1Y83.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year74.52%
EBIT Next 3Y28.48%
EBIT Next 5Y22.63%
FCF growth 1Y84.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y87.85%
OCF growth 3YN/A
OCF growth 5YN/A

UIPATH INC - CLASS A / PATH FAQ

What is the fundamental rating for PATH stock?

ChartMill assigns a fundamental rating of 5 / 10 to PATH.


Can you provide the valuation status for UIPATH INC - CLASS A?

ChartMill assigns a valuation rating of 4 / 10 to UIPATH INC - CLASS A (PATH). This can be considered as Fairly Valued.


How profitable is UIPATH INC - CLASS A (PATH) stock?

UIPATH INC - CLASS A (PATH) has a profitability rating of 3 / 10.


How financially healthy is UIPATH INC - CLASS A?

The financial health rating of UIPATH INC - CLASS A (PATH) is 8 / 10.